Vacuna antineumocócica conjugada de quince serotipos en niños pequeños
Lupinacci R, Rupp R, Wittawatmongkol O et al. A phase 3, multicenter, randomized, double-blind, active-comparator controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED). Vaccine available on line January 6, 2023 https://doi.org/10.1016/j.vaccine.2022.12.054 Fase III de un ensayo clínico pivotal aleatorio,…
Detalles